Reports

Industry Research Reports

Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-10-29

Pages: 109 Pages

Report ld: 5290171

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Iohexol Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

6.9%

marketSize

Market Size,2031

USD 1,073

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 719 million
Market Forecast in 2031(Value)
US$ 1,073 million
CAGR
6.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Iohexol was estimated to be worth US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Iohexol cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Iohexol is a non-ionic, iodinated radiocontrast agent used to enhance visibility of anatomical structures in X-ray based imaging procedures (CT, angiography, myelography, urography, joint studies and other contrast-enhanced scans). The active pharmaceutical ingredient (API) — chemically an organoiodine compound — is supplied to formulators of finished contrast media (sterile injectable solutions, oral/rectal solutions for bowel studies, or intrathecal preparations) and, in some cases, to manufacturers of specialty laboratory reagents that use iodinated density media. In commercial terms the “Iohexol API market” therefore covers: production and sale of technical- and pharmaceutical-grade Iohexol (including batches certified to pharmacopeial standards); regulatory documentation such as Drug Master Files (DMFs) and certificates of analysis supplied to finished product manufacturers; contract manufacturing (CMO) and custom synthesis for brand and generic contrast media producers; and the downstream finished-dosage contrast media market that ultimately consumes the API.

Iohexol sold into the pharmaceutical channel must meet stringent purity, identity, and particulate/sterility standards appropriate for parenteral use; producers commonly supply documentation aligned with pharmacopeial monographs and regulatory expectations for injectable contrast media. Because finished contrast products are administered intravenously, intrathecally, or orally for diagnostic imaging, the API’s manufacturing process, residual solvent profile, heavy-metal content, and impurity profile are central to market acceptability. Compliance with pharmacopeial monographs and the ability to support regulatory filings (e.g., provision of a US DMF, CEP for EU markets, or equivalent dossiers) are usual entry barriers for suppliers.

In 2024, global Iohexol production reached approximately 5,545.5 MT, with an average global market price of around US$ 121.5 per kg. The global single-line production capacity ranges from 500 to 800 MT per year. The industry's gross profit margin is approximately 35%-45%.

Demand for Iohexol is driven by the global use of contrast-enhanced imaging in hospitals, outpatient imaging centers, interventional radiology, cardiology suites, and surgical planning. The primary use is in computed tomography (CT) angiography and general CT imaging to delineate blood vessels, organs, and lesions; it is also used in intrathecal myelography and specialized procedures. Growth drivers on the demand side typically include expansion of medical imaging capacity (new CT installations and interventional suites), ageing populations with higher imaging utilization, rising incidence and detection of chronic diseases (cardiovascular disease, cancer), and broader adoption of minimally invasive image-guided procedures that require high-quality contrast agents. In many clinical pathways, contrast media are integral to diagnostic accuracy, so demand is relatively inelastic to small price fluctuations — although procurement practice and tendering by hospitals, health systems, and large distributors can exert strong price pressure.

The Iohexol market is a technically and regulatory-intensive niche within the broader contrast media and radiopharmaceutical supply chain. Its demand is underpinned by durable clinical needs — diagnostic CT and image-guided procedures — with steady growth driven by demographic changes and expanding global imaging capacity. Market developments will be shaped by: regulatory expectations (pharmacopeial alignment, DMFs), procurement behavior (tendering and generic competition), supplier capability (GMP/DMF/CEP credentials), and regional investment in imaging infrastructure. While substitution risk is limited for many CT applications, cost pressure, supply reliability, and environmental/regulatory compliance will continue to drive supplier consolidation, vertical integration, and selective capacity investments. For new entrants, the combination of capital-intensive quality systems and the need to support regulatory dossiers makes the market accessible mainly to established API manufacturers or CMOs that can rapidly meet pharmacopeial and regulatory demands.

Global key manufacturers of Iohexol include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%.

This report aims to provide a comprehensive presentation of the global market for Iohexol, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Iohexol by region & country, by Type, and by Application.

The Iohexol market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol.

MARKET SEGMENTATION

By Company

  • Zhejiang Hichi Pharmaceutical
  • GE Healthcare
  • Zhejiang Starry Pharmaceutical
  • Otsuka Chemicals
  • Justesa Imagen
  • Beijing Beilu Pharmaceutical

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Original Drug
  • Generic Drug

Segment by Application

  • Contrast Agents
  • Diagnostic Agents
  • Others

Segment by Category

  • Pharmaceutical Grade (GMP-Grade)
  • Technical or Laboratory Grade
  • Custom Purity Grades

Segment by Division

  • Standard Assay (≥ 99.0%)
  • High Assay (≥ 99.5%)
  • Research or Technical Grade (≥ 97–98%)

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Iohexol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Sales, revenue of Iohexol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Sales, revenue of Iohexol in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Iohexol Product Introduction

1.2 Global Iohexol Market Size Forecast

1.2.1 Global Iohexol Sales Value (2020-2031)

1.2.2 Global Iohexol Sales Volume (2020-2031)

1.2.3 Global Iohexol Sales Price (2020-2031)

1.3 Iohexol Market Trends & Drivers

1.3.1 Iohexol Industry Trends

1.3.2 Iohexol Market Drivers & Opportunity

1.3.3 Iohexol Market Challenges

1.3.4 Iohexol Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Iohexol Players Revenue Ranking (2024)

2.2 Global Iohexol Revenue by Company (2020-2025)

2.3 Global Iohexol Players Sales Volume Ranking (2024)

2.4 Global Iohexol Sales Volume by Company Players (2020-2025)

2.5 Global Iohexol Average Price by Company (2020-2025)

2.6 Key Manufacturers Iohexol Manufacturing Base and Headquarters

2.7 Key Manufacturers Iohexol Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Iohexol

2.9 Iohexol Market Competitive Analysis

2.9.1 Iohexol Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Iohexol Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iohexol as of 2024)

2.10 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Original Drug

3.1.2 Generic Drug

3.2 Global Iohexol Sales Value by Type

3.2.1 Global Iohexol Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Iohexol Sales Value, by Type (2020-2031)

3.2.3 Global Iohexol Sales Value, by Type (%) (2020-2031)

3.3 Global Iohexol Sales Volume by Type

3.3.1 Global Iohexol Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Iohexol Sales Volume, by Type (2020-2031)

3.3.3 Global Iohexol Sales Volume, by Type (%) (2020-2031)

3.4 Global Iohexol Average Price by Type (2020-2031)

muLu

4 Segmentation by Purity and Quality Grade

4.1 Introduction by Purity and Quality Grade

4.1.1 Pharmaceutical Grade (GMP-Grade)

4.1.2 Technical or Laboratory Grade

4.1.3 Custom Purity Grades

4.2 Global Iohexol Sales Value by Purity and Quality Grade

4.2.1 Global Iohexol Sales Value by Purity and Quality Grade (2020 VS 2024 VS 2031)

4.2.2 Global Iohexol Sales Value, by Purity and Quality Grade (2020-2031)

4.2.3 Global Iohexol Sales Value, by Purity and Quality Grade (%) (2020-2031)

4.3 Global Iohexol Sales Volume by Purity and Quality Grade

4.3.1 Global Iohexol Sales Volume by Purity and Quality Grade (2020 VS 2024 VS 2031)

4.3.2 Global Iohexol Sales Volume, by Purity and Quality Grade (2020-2031)

4.3.3 Global Iohexol Sales Volume, by Purity and Quality Grade (%) (2020-2031)

4.4 Global Iohexol Average Price by Purity and Quality Grade (2020-2031)

muLu

5 Segmentation by Assay (Content of Iohexol)

5.1 Introduction by Assay (Content of Iohexol)

5.1.1 Standard Assay (≥ 99.0%)

5.1.2 High Assay (≥ 99.5%)

5.1.3 Research or Technical Grade (≥ 97–98%)

5.2 Global Iohexol Sales Value by Assay (Content of Iohexol)

5.2.1 Global Iohexol Sales Value by Assay (Content of Iohexol) (2020 VS 2024 VS 2031)

5.2.2 Global Iohexol Sales Value, by Assay (Content of Iohexol) (2020-2031)

5.2.3 Global Iohexol Sales Value, by Assay (Content of Iohexol) (%) (2020-2031)

5.3 Global Iohexol Sales Volume by Assay (Content of Iohexol)

5.3.1 Global Iohexol Sales Volume by Assay (Content of Iohexol) (2020 VS 2024 VS 2031)

5.3.2 Global Iohexol Sales Volume, by Assay (Content of Iohexol) (2020-2031)

5.3.3 Global Iohexol Sales Volume, by Assay (Content of Iohexol) (%) (2020-2031)

5.4 Global Iohexol Average Price by Assay (Content of Iohexol) (2020-2031)

muLu

6 Segmentation by Application

6.1 Introduction by Application

6.1.1 Contrast Agents

6.1.2 Diagnostic Agents

6.1.3 Others

6.2 Global Iohexol Sales Value by Application

6.2.1 Global Iohexol Sales Value by Application (2020 VS 2024 VS 2031)

6.2.2 Global Iohexol Sales Value, by Application (2020-2031)

6.2.3 Global Iohexol Sales Value, by Application (%) (2020-2031)

6.3 Global Iohexol Sales Volume by Application

6.3.1 Global Iohexol Sales Volume by Application (2020 VS 2024 VS 2031)

6.3.2 Global Iohexol Sales Volume, by Application (2020-2031)

6.3.3 Global Iohexol Sales Volume, by Application (%) (2020-2031)

6.4 Global Iohexol Average Price by Application (2020-2031)

muLu

7 Segmentation by Region

7.1 Global Iohexol Sales Value by Region

7.1.1 Global Iohexol Sales Value by Region: 2020 VS 2024 VS 2031

7.1.2 Global Iohexol Sales Value by Region (2020-2025)

7.1.3 Global Iohexol Sales Value by Region (2026-2031)

7.1.4 Global Iohexol Sales Value by Region (%), (2020-2031)

7.2 Global Iohexol Sales Volume by Region

7.2.1 Global Iohexol Sales Volume by Region: 2020 VS 2024 VS 2031

7.2.2 Global Iohexol Sales Volume by Region (2020-2025)

7.2.3 Global Iohexol Sales Volume by Region (2026-2031)

7.2.4 Global Iohexol Sales Volume by Region (%), (2020-2031)

7.3 Global Iohexol Average Price by Region (2020-2031)

7.4 North America

7.4.1 North America Iohexol Sales Value, 2020-2031

7.4.2 North America Iohexol Sales Value by Country (%), 2024 VS 2031

7.5 Europe

7.5.1 Europe Iohexol Sales Value, 2020-2031

7.5.2 Europe Iohexol Sales Value by Country (%), 2024 VS 2031

7.6 Asia Pacific

7.6.1 Asia Pacific Iohexol Sales Value, 2020-2031

7.6.2 Asia Pacific Iohexol Sales Value by Region (%), 2024 VS 2031

7.7 South America

7.7.1 South America Iohexol Sales Value, 2020-2031

7.7.2 South America Iohexol Sales Value by Country (%), 2024 VS 2031

7.8 Middle East & Africa

7.8.1 Middle East & Africa Iohexol Sales Value, 2020-2031

7.8.2 Middle East & Africa Iohexol Sales Value by Country (%), 2024 VS 2031

muLu

8 Segmentation by Key Countries/Regions

8.1 Key Countries/Regions Iohexol Sales Value Growth Trends, 2020 VS 2024 VS 2031

8.2 Key Countries/Regions Iohexol Sales Value and Sales Volume

8.2.1 Key Countries/Regions Iohexol Sales Value, 2020-2031

8.2.2 Key Countries/Regions Iohexol Sales Volume, 2020-2031

8.3 United States

8.3.1 United States Iohexol Sales Value, 2020-2031

8.3.2 United States Iohexol Sales Value by Type (%), 2024 VS 2031

8.3.3 United States Iohexol Sales Value by Application, 2024 VS 2031

8.4 Europe

8.4.1 Europe Iohexol Sales Value, 2020-2031

8.4.2 Europe Iohexol Sales Value by Type (%), 2024 VS 2031

8.4.3 Europe Iohexol Sales Value by Application, 2024 VS 2031

8.5 China

8.5.1 China Iohexol Sales Value, 2020-2031

8.5.2 China Iohexol Sales Value by Type (%), 2024 VS 2031

8.5.3 China Iohexol Sales Value by Application, 2024 VS 2031

8.6 Japan

8.6.1 Japan Iohexol Sales Value, 2020-2031

8.6.2 Japan Iohexol Sales Value by Type (%), 2024 VS 2031

8.6.3 Japan Iohexol Sales Value by Application, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Iohexol Sales Value, 2020-2031

8.7.2 South Korea Iohexol Sales Value by Type (%), 2024 VS 2031

8.7.3 South Korea Iohexol Sales Value by Application, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Iohexol Sales Value, 2020-2031

8.8.2 Southeast Asia Iohexol Sales Value by Type (%), 2024 VS 2031

8.8.3 Southeast Asia Iohexol Sales Value by Application, 2024 VS 2031

8.9 India

8.9.1 India Iohexol Sales Value, 2020-2031

8.9.2 India Iohexol Sales Value by Type (%), 2024 VS 2031

8.9.3 India Iohexol Sales Value by Application, 2024 VS 2031

muLu

9 Company Profiles

9.1 Zhejiang Hichi Pharmaceutical

9.1.1 Zhejiang Hichi Pharmaceutical Company Information

9.1.2 Zhejiang Hichi Pharmaceutical Introduction and Business Overview

9.1.3 Zhejiang Hichi Pharmaceutical Iohexol Sales, Revenue, Price and Gross Margin (2020-2025)

9.1.4 Zhejiang Hichi Pharmaceutical Iohexol Product Offerings

9.1.5 Zhejiang Hichi Pharmaceutical Recent Development

9.2 GE Healthcare

9.2.1 GE Healthcare Company Information

9.2.2 GE Healthcare Introduction and Business Overview

9.2.3 GE Healthcare Iohexol Sales, Revenue, Price and Gross Margin (2020-2025)

9.2.4 GE Healthcare Iohexol Product Offerings

9.2.5 GE Healthcare Recent Development

9.3 Zhejiang Starry Pharmaceutical

9.3.1 Zhejiang Starry Pharmaceutical Company Information

9.3.2 Zhejiang Starry Pharmaceutical Introduction and Business Overview

9.3.3 Zhejiang Starry Pharmaceutical Iohexol Sales, Revenue, Price and Gross Margin (2020-2025)

9.3.4 Zhejiang Starry Pharmaceutical Iohexol Product Offerings

9.3.5 Zhejiang Starry Pharmaceutical Recent Development

9.4 Otsuka Chemicals

9.4.1 Otsuka Chemicals Company Information

9.4.2 Otsuka Chemicals Introduction and Business Overview

9.4.3 Otsuka Chemicals Iohexol Sales, Revenue, Price and Gross Margin (2020-2025)

9.4.4 Otsuka Chemicals Iohexol Product Offerings

9.4.5 Otsuka Chemicals Recent Development

9.5 Justesa Imagen

9.5.1 Justesa Imagen Company Information

9.5.2 Justesa Imagen Introduction and Business Overview

9.5.3 Justesa Imagen Iohexol Sales, Revenue, Price and Gross Margin (2020-2025)

9.5.4 Justesa Imagen Iohexol Product Offerings

9.5.5 Justesa Imagen Recent Development

9.6 Beijing Beilu Pharmaceutical

9.6.1 Beijing Beilu Pharmaceutical Company Information

9.6.2 Beijing Beilu Pharmaceutical Introduction and Business Overview

9.6.3 Beijing Beilu Pharmaceutical Iohexol Sales, Revenue, Price and Gross Margin (2020-2025)

9.6.4 Beijing Beilu Pharmaceutical Iohexol Product Offerings

9.6.5 Beijing Beilu Pharmaceutical Recent Development

muLu

10 Industry Chain Analysis

10.1 Iohexol Industrial Chain

10.2 Iohexol Upstream Analysis

10.2.1 Key Raw Materials

10.2.2 Raw Materials Key Suppliers

10.2.3 Manufacturing Cost Structure

10.3 Midstream Analysis

10.4 Downstream Analysis (Customers Analysis)

10.5 Sales Model and Sales Channels

10.5.1 Iohexol Sales Model

10.5.2 Sales Channel

10.5.3 Iohexol Distributors

muLu

11 Research Findings and Conclusion

muLu

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Iohexol Market Trends
Table 2. Iohexol Market Drivers & Opportunity
Table 3. Iohexol Market Challenges
Table 4. Iohexol Market Restraints
Table 5. Global Iohexol Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Iohexol Revenue Market Share by Company (2020-2025)
Table 7. Global Iohexol Sales Volume by Company (2020-2025) & (MT)
Table 8. Global Iohexol Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Iohexol Price by Company (2020-2025) & (US$/Kg)
Table 10. Key Manufacturers Iohexol Manufacturing Base and Headquarters
Table 11. Key Manufacturers Iohexol Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Iohexol
Table 13. Global Iohexol Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iohexol as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Iohexol Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Iohexol Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Iohexol Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Iohexol Sales Market Share in Value by Type (2020-2025)
Table 20. Global Iohexol Sales Market Share in Value by Type (2026-2031)
Table 21. Global Iohexol Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Iohexol Sales Volume by Type (2020-2025) & (MT)
Table 23. Global Iohexol Sales Volume by Type (2026-2031) & (MT)
Table 24. Global Iohexol Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Iohexol Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Iohexol Price by Type (2020-2025) & (US$/Kg)
Table 27. Global Iohexol Price by Type (2026-2031) & (US$/Kg)
Table 28. Global Iohexol Sales Value by Purity and Quality Grade: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Iohexol Sales Value by Purity and Quality Grade (2020-2025) & (US$ Million)
Table 30. Global Iohexol Sales Value by Purity and Quality Grade (2026-2031) & (US$ Million)
Table 31. Global Iohexol Sales Market Share in Value by Purity and Quality Grade (2020-2025)
Table 32. Global Iohexol Sales Market Share in Value by Purity and Quality Grade (2026-2031)
Table 33. Global Iohexol Sales Volume by Purity and Quality Grade: 2020 VS 2024 VS 2031 (MT)
Table 34. Global Iohexol Sales Volume by Purity and Quality Grade (2020-2025) & (MT)
Table 35. Global Iohexol Sales Volume by Purity and Quality Grade (2026-2031) & (MT)
Table 36. Global Iohexol Sales Market Share in Volume by Purity and Quality Grade (2020-2025)
Table 37. Global Iohexol Sales Market Share in Volume by Purity and Quality Grade (2026-2031)
Table 38. Global Iohexol Price by Purity and Quality Grade (2020-2025) & (US$/Kg)
Table 39. Global Iohexol Price by Purity and Quality Grade (2026-2031) & (US$/Kg)
Table 40. Global Iohexol Sales Value by Assay (Content of Iohexol): 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Global Iohexol Sales Value by Assay (Content of Iohexol) (2020-2025) & (US$ Million)
Table 42. Global Iohexol Sales Value by Assay (Content of Iohexol) (2026-2031) & (US$ Million)
Table 43. Global Iohexol Sales Market Share in Value by Assay (Content of Iohexol) (2020-2025)
Table 44. Global Iohexol Sales Market Share in Value by Assay (Content of Iohexol) (2026-2031)
Table 45. Global Iohexol Sales Volume by Assay (Content of Iohexol): 2020 VS 2024 VS 2031 (MT)
Table 46. Global Iohexol Sales Volume by Assay (Content of Iohexol) (2020-2025) & (MT)
Table 47. Global Iohexol Sales Volume by Assay (Content of Iohexol) (2026-2031) & (MT)
Table 48. Global Iohexol Sales Market Share in Volume by Assay (Content of Iohexol) (2020-2025)
Table 49. Global Iohexol Sales Market Share in Volume by Assay (Content of Iohexol) (2026-2031)
Table 50. Global Iohexol Price by Assay (Content of Iohexol) (2020-2025) & (US$/Kg)
Table 51. Global Iohexol Price by Assay (Content of Iohexol) (2026-2031) & (US$/Kg)
Table 52. Global Iohexol Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 53. Global Iohexol Sales Value by Application (2020-2025) & (US$ Million)
Table 54. Global Iohexol Sales Value by Application (2026-2031) & (US$ Million)
Table 55. Global Iohexol Sales Market Share in Value by Application (2020-2025)
Table 56. Global Iohexol Sales Market Share in Value by Application (2026-2031)
Table 57. Global Iohexol Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
Table 58. Global Iohexol Sales Volume by Application (2020-2025) & (MT)
Table 59. Global Iohexol Sales Volume by Application (2026-2031) & (MT)
Table 60. Global Iohexol Sales Market Share in Volume by Application (2020-2025)
Table 61. Global Iohexol Sales Market Share in Volume by Application (2026-2031)
Table 62. Global Iohexol Price by Application (2020-2025) & (US$/Kg)
Table 63. Global Iohexol Price by Application (2026-2031) & (US$/Kg)
Table 64. Global Iohexol Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 65. Global Iohexol Sales Value by Region (2020-2025) & (US$ Million)
Table 66. Global Iohexol Sales Value by Region (2026-2031) & (US$ Million)
Table 67. Global Iohexol Sales Value by Region (2020-2025) & (%)
Table 68. Global Iohexol Sales Value by Region (2026-2031) & (%)
Table 69. Global Iohexol Sales Volume by Region (MT): 2020 VS 2024 VS 2031
Table 70. Global Iohexol Sales Volume by Region (2020-2025) & (MT)
Table 71. Global Iohexol Sales Volume by Region (2026-2031) & (MT)
Table 72. Global Iohexol Sales Volume by Region (2020-2025) & (%)
Table 73. Global Iohexol Sales Volume by Region (2026-2031) & (%)
Table 74. Global Iohexol Average Price by Region (2020-2025) & (US$/Kg)
Table 75. Global Iohexol Average Price by Region (2026-2031) & (US$/Kg)
Table 76. Key Countries/Regions Iohexol Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 77. Key Countries/Regions Iohexol Sales Value, (2020-2025) & (US$ Million)
Table 78. Key Countries/Regions Iohexol Sales Value, (2026-2031) & (US$ Million)
Table 79. Key Countries/Regions Iohexol Sales Volume, (2020-2025) & (MT)
Table 80. Key Countries/Regions Iohexol Sales Volume, (2026-2031) & (MT)
Table 81. Zhejiang Hichi Pharmaceutical Company Information
Table 82. Zhejiang Hichi Pharmaceutical Introduction and Business Overview
Table 83. Zhejiang Hichi Pharmaceutical Iohexol Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 84. Zhejiang Hichi Pharmaceutical Iohexol Product Offerings
Table 85. Zhejiang Hichi Pharmaceutical Recent Development
Table 86. GE Healthcare Company Information
Table 87. GE Healthcare Introduction and Business Overview
Table 88. GE Healthcare Iohexol Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 89. GE Healthcare Iohexol Product Offerings
Table 90. GE Healthcare Recent Development
Table 91. Zhejiang Starry Pharmaceutical Company Information
Table 92. Zhejiang Starry Pharmaceutical Introduction and Business Overview
Table 93. Zhejiang Starry Pharmaceutical Iohexol Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 94. Zhejiang Starry Pharmaceutical Iohexol Product Offerings
Table 95. Zhejiang Starry Pharmaceutical Recent Development
Table 96. Otsuka Chemicals Company Information
Table 97. Otsuka Chemicals Introduction and Business Overview
Table 98. Otsuka Chemicals Iohexol Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 99. Otsuka Chemicals Iohexol Product Offerings
Table 100. Otsuka Chemicals Recent Development
Table 101. Justesa Imagen Company Information
Table 102. Justesa Imagen Introduction and Business Overview
Table 103. Justesa Imagen Iohexol Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 104. Justesa Imagen Iohexol Product Offerings
Table 105. Justesa Imagen Recent Development
Table 106. Beijing Beilu Pharmaceutical Company Information
Table 107. Beijing Beilu Pharmaceutical Introduction and Business Overview
Table 108. Beijing Beilu Pharmaceutical Iohexol Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 109. Beijing Beilu Pharmaceutical Iohexol Product Offerings
Table 110. Beijing Beilu Pharmaceutical Recent Development
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Iohexol Downstream Customers
Table 114. Iohexol Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Iohexol Product Picture
Figure 2. Global Iohexol Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Iohexol Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Iohexol Sales Volume (2020-2031) & (MT)
Figure 5. Global Iohexol Sales Price (2020-2031) & (US$/Kg)
Figure 6. Iohexol Report Years Considered
Figure 7. Global Iohexol Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Iohexol Players Sales Volume Ranking (2024) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Iohexol Revenue in 2024
Figure 10. Iohexol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Original Drug Picture
Figure 12. Generic Drug Picture
Figure 13. Global Iohexol Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Iohexol Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Iohexol Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
Figure 16. Global Iohexol Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Iohexol Price by Type (2020-2031) & (US$/Kg)
Figure 18. Pharmaceutical Grade (GMP-Grade) Picture
Figure 19. Technical or Laboratory Grade Picture
Figure 20. Custom Purity Grades Picture
Figure 21. Global Iohexol Sales Value by Purity and Quality Grade (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Iohexol Sales Value Market Share by Purity and Quality Grade, 2024 & 2031
Figure 23. Global Iohexol Sales Volume by Purity and Quality Grade (2020 VS 2024 VS 2031) & (MT)
Figure 24. Global Iohexol Sales Volume Market Share by Purity and Quality Grade, 2024 & 2031
Figure 25. Global Iohexol Price by Purity and Quality Grade (2020-2031) & (US$/Kg)
Figure 26. Standard Assay (≥ 99.0%) Picture
Figure 27. High Assay (≥ 99.5%) Picture
Figure 28. Research or Technical Grade (≥ 97–98%) Picture
Figure 29. Global Iohexol Sales Value by Assay (Content of Iohexol) (2020 VS 2024 VS 2031) & (US$ Million)
Figure 30. Global Iohexol Sales Value Market Share by Assay (Content of Iohexol), 2024 & 2031
Figure 31. Global Iohexol Sales Volume by Assay (Content of Iohexol) (2020 VS 2024 VS 2031) & (MT)
Figure 32. Global Iohexol Sales Volume Market Share by Assay (Content of Iohexol), 2024 & 2031
Figure 33. Global Iohexol Price by Assay (Content of Iohexol) (2020-2031) & (US$/Kg)
Figure 34. Product Picture of Contrast Agents
Figure 35. Product Picture of Diagnostic Agents
Figure 36. Product Picture of Others
Figure 37. Global Iohexol Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 38. Global Iohexol Sales Value Market Share by Application, 2024 & 2031
Figure 39. Global Iohexol Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
Figure 40. Global Iohexol Sales Volume Market Share by Application, 2024 & 2031
Figure 41. Global Iohexol Price by Application (2020-2031) & (US$/Kg)
Figure 42. North America Iohexol Sales Value (2020-2031) & (US$ Million)
Figure 43. North America Iohexol Sales Value by Country (%), 2024 VS 2031
Figure 44. Europe Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Iohexol Sales Value by Country (%), 2024 VS 2031
Figure 46. Asia Pacific Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 47. Asia Pacific Iohexol Sales Value by Region (%), 2024 VS 2031
Figure 48. South America Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 49. South America Iohexol Sales Value by Country (%), 2024 VS 2031
Figure 50. Middle East & Africa Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Iohexol Sales Value by Country (%), 2024 VS 2031
Figure 52. Key Countries/Regions Iohexol Sales Value (%), (2020-2031)
Figure 53. Key Countries/Regions Iohexol Sales Volume (%), (2020-2031)
Figure 54. United States Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 55. United States Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 56. United States Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 57. Europe Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 58. Europe Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 59. Europe Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 60. China Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 61. China Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 62. China Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 63. Japan Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 64. Japan Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 65. Japan Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 66. South Korea Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 67. South Korea Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 68. South Korea Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 69. Southeast Asia Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 70. Southeast Asia Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 71. Southeast Asia Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 72. India Iohexol Sales Value, (2020-2031) & (US$ Million)
Figure 73. India Iohexol Sales Value by Type (%), 2024 VS 2031
Figure 74. India Iohexol Sales Value by Application (%), 2024 VS 2031
Figure 75. Iohexol Industrial Chain
Figure 76. Iohexol Manufacturing Cost Structure
Figure 77. Channels of Distribution (Direct Sales, and Distribution)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Iohexol market?zhanKai
The top companies in the global Iohexol market are Zhejiang Hichi Pharmaceutical、GE Healthcare、Zhejiang Starry Pharmaceutical.
What is the annual compound growth rate of the global Iohexol market size from 2025 to 2031?shouQi
What was the global market size of Iohexol in 2031?shouQi
What was the global market size of Iohexol in 2025?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-10-29

Pages: 109 Pages

Report ld: 5290171

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now